Page last updated: 2024-08-21

aminoimidazole carboxamide and Angor Pectoris

aminoimidazole carboxamide has been researched along with Angor Pectoris in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iso, T; Kawakami, R; Koitabashi, N; Kurabayashi, M; Matsui, H; Murakami, M; Obokata, M; Sunaga, H; Yokoyama, T1
Fox, KM; Holdright, DR; Sparrow, JL; Steiner, J; Wright, CL1

Trials

1 trial(s) available for aminoimidazole carboxamide and Angor Pectoris

ArticleYear
Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.
    Cardiovascular drugs and therapy, 1994, Volume: 8, Issue:2

    Topics: Aged; Aminoimidazole Carboxamide; Angina Pectoris; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Exercise Test; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Placebos; Ribonucleosides; Time Factors

1994

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Angor Pectoris

ArticleYear
Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts.
    Scientific reports, 2019, 08-14, Volume: 9, Issue:1

    Topics: Adrenergic Agents; Aged; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angina Pectoris; Animals; Catecholamines; Disease Models, Animal; Fatty Acid-Binding Proteins; Fatty Acids; Female; Fibroblast Growth Factors; Humans; Lipolysis; Male; Multivariate Analysis; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Recombinant Proteins; Ribonucleotides; Time Factors; Troponin T

2019